This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Exelixis, Inc.. Active years: 2020-2023.
Location History:
- Los Altos Hills, CA (US) (2020 - 2022)
- Menlo Park, CA (US) (2023)
Company Filing History:
Years Active: 2020-2023
Title: The Innovative Contributions of Aaron Weitzman
Introduction
Aaron Weitzman is a notable inventor based in Los Altos Hills, California. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of three patents to his name, Weitzman has focused on developing advanced methods and formulations to combat cancer effectively.
Latest Patents
Weitzman's latest patents include a dosage form of cabozantinib and a method of employing this dosage form to treat cancer. This invention relates specifically to the formulation of cabozantinib, which is crucial in the fight against cancer. Another significant patent involves methods of using c-Met modulators, which describe ways to treat cancer by administering a specific compound in combination with other cancer treatments.
Career Highlights
Aaron Weitzman is currently associated with Exelixis, Inc., a company known for its focus on developing innovative cancer therapies. His work at Exelixis has allowed him to contribute to groundbreaking research and development in oncology.
Collaborations
Weitzman has collaborated with several professionals in his field, including Dana T Aftab and Thomas Mueller. These collaborations have further enhanced his research and development efforts in cancer treatment.
Conclusion
Aaron Weitzman's contributions to cancer treatment through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to impact the field positively, offering hope for improved cancer therapies.